Table 1.
Survey 1 | Survey 2 | Survey 3 | |
---|---|---|---|
n = 203 | n = 100a | n = 200 | |
Age, median (IQR), years | 39 (30–53) | 33 (25–45) | 40 (30–50) |
Male, n/N (%) | 102/203 (50.2) | 447/100 (47.0) | 103/200 (51.5) |
Living with HIV, n/N (%) | 122/198 (61.6) | 49/85(57.6) | 118/193(61.1) |
5 unknown | 15 unknown | 7 unknown | |
On ART if living with HIV, n/N (%) | 98/122 (80.3) | 39/49 (79.6) | 96/118 (81.4) |
LOS, median (IQR), days | 7 (4–10) | 7 (4–9) | 7 (5–12) |
In-hospital case-fatality, n/N (%) | 30/193 (15.5) | 17/100 (17.0) | 22/172 (12.8) |
% (95% CI) | unknown outcome = 10 | unknown outcome = 8 |
Abbreviations: ART, antiretroviral therapy; CI, confidence interval; HIV, human immunodeficiency virus; IQR, interquartile range; LOS, length of stay.
aNote that Survey 2 was smaller than Surveys 1 and 3 because of limited personnel available at the time of the survey.